EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of Patient-Derived Organoids for Pediatric Cancer Research

Muhammad Younis, Tarlan Arjmandi, Mohammad Haque, Katherine McClain, Thussenthan Walter-Angelo iD, Franklin Back iD, Divya Gandra, Abigail Moore, Chandrika Behura iD, Vladimir S Spiegelman iD, Hong-Gang Wang iD, Sinisa Dovat und 2 weitere

Cancers · 02.05.2026 · 18 (9) · 1465

DOI: 10.3390/cancers18091465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 02.05.2026. Verfasst von Muhammad Younis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Hematology/Oncology, College of Medicine, Pennsylvania State University, Hershey, PA 17033, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Four Diamonds, Beat Childhood Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Pediatric cancers are disorders of dysregulated development driven largely by genomic and epigenetic alterations. Precisely modeling these developmental differences is essential for understanding the unique biology of childhood cancers. Patient-derived organoids (PDOs) offer a powerful in vitro platform that recapitulates tumor heterogeneity, plasticity, microenvironment (including immune cells) and disease-relevant features.

Methods

Here, we describe a step-by-step protocol for the establishment of PDOs from cells derived from pediatric brain tumors and extracranial solid tumor biopsies and bone marrow aspirates, including tumor processing, organoid culture/subculture, and cryopreservation.

Results

Furthermore, we present the use of PDOs for further experimental analysis such as fluorescence imaging, Western blotting, flow cytometry, and immunohistochemistry (IHC) to investigate the underlying pathophysiology of tumorigenesis.

Conclusions

Expanding the application of organoids to childhood malignancies holds exceptional promise for elucidating pediatric tumor biology and advancing therapeutic strategies, representing the long-overdue convergence of technology and clinical need.

Schlagwörter

Stichwörter der Autor:innen

patient derived organoidspediatric cancerpreclinical model

Autor:innen und Institutionen

  • Department of Pediatrics, Hematology/Oncology, College of Medicine, Pennsylvania State University, Hershey, PA 17033, USA.
  • Pediatric Hematology and Oncology Division, Pennsylvania State University, Golisano Children's Hospital, Hershey, PA 17033, USA.

ORCID-Profile: Thussenthan Walter-Angelo, Franklin Back, Chandrika Behura, Vladimir S Spiegelman, Hong-Gang Wang, Jeremy Hengst

Förderung

  • Four Diamonds
  • Beat Childhood Cancer Foundation

Zitieren

APA

Younis, M., Arjmandi, T., Haque, M., McClain, K., Walter-Angelo, T., Back, F., Gandra, D., Moore, A., Behura, C., Spiegelman, V. S., Wang, H. G., Dovat, S., Hengst, J., & Sholler, G. S. (2026). Establishment of Patient-Derived Organoids for Pediatric Cancer Research. Cancers, 18(9), 1465. https://doi.org/10.3390/cancers18091465

Vancouver

Younis M, Arjmandi T, Haque M, McClain K, Walter-Angelo T, Back F, et al. Establishment of Patient-Derived Organoids for Pediatric Cancer Research. Cancers. 2026;18(9):1465. doi:10.3390/cancers18091465

BibTeX
@article{Younis2026,
  author = {Younis, Muhammad and Arjmandi, Tarlan and Haque, Mohammad and McClain, Katherine and Walter-Angelo, Thussenthan and Back, Franklin and Gandra, Divya and Moore, Abigail and Behura, Chandrika and Spiegelman, Vladimir S and Wang, Hong-Gang and Dovat, Sinisa and Hengst, Jeremy and Sholler, Giselle Saulnier},
  title = {Establishment of Patient-Derived Organoids for Pediatric Cancer Research},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {1465},
  doi = {10.3390/cancers18091465}
}
Kostenlos starten →